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Abstract 
A method to directly collect negatively charged nucleic acids, such as DNA and RNA, in the biosamples simply by 
applying an electric field in between the sample and collection buffer separated by the nanofilter membrane is 
proposed. The nanofilter membrane was made of low‑stress silicon nitride with a thickness of 100 nm, and multiple 
pores were perforated in a highly arranged pattern using nanoimprint technology with a pore size of 200 nm and a 
pore density of 7.22 × 108/cm2. The electrophoretic transport of hsa‑mir‑93‑5p across the membrane was confirmed 
in pure microRNA (miRNA) mimic solution using quantitative reverse transcription‑polymerase chain reactions (qRT‑
PCR). Consistency of the collected miRNA quantity, stability of the system during the experiment, and yield and purity 
of the prepared sample were discussed in detail to validate the effectiveness of the electrical protocol. Finally, in order 
to check the applicability of this method to clinical samples, liquid biopsy process was demonstrated by evaluating 
the miRNA levels in sera of hepatocellular carcinoma patients and healthy controls. This efficient system proposed a 
simple, physical idea in preparation of nucleic acid from biosamples, and demonstrated its compatibility to biological 
downstream applications such as qRT‑PCR as the conventional nucleic acid extraction protocols.
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1 Introduction
In genetic analysis of clinical samples, nucleic acid extrac-
tion from raw biosamples is the initial pre-treatment step 
to purify and concentrate the nucleic acid from other 
constituents of the samples including proteins, lipids, and 
other organic molecules. One of the mainstream solid-
phase extraction techniques is based on the charge inter-
action principle, using a surface modified binding media 
such as silica bead (or membrane) or magnetic bead to 
selectively collect the nucleic acid from the sample and 
ethanol-based buffers to wash out impurities [1–5]. 
While this method and related products are well estab-
lished [6–9], it normally constitutes more than 10 steps, 
thus requires substantial time and skilled personnel to 
produce stable extraction results. In addition, apparatus 
such as centrifuge and heating blocks should be used 
in the chemical processes to lyse the cells, separate the 
nucleic acids, and clear away the unnecessary organic 
residues [3, 6]. Consequently, the nucleic acid extraction 
protocols spatially limit the genetic analysis to a labora-
tory procedure, making it difficult to expand to quick and 
handy on-site detection of the target gene in biological or 
clinical samples [3].
The complexity of the conventional nucleic acid extrac-
tion method led to the introduction of alternative tech-
niques, which have focused on simplifying the process 
and reducing the extraction time [4, 6]. Among the 
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reported strategies, lab-on-a-chip approaches targeted 
systemization of the procedure by integrating the extrac-
tion column, binding media, and buffers in a single device 
[5, 6, 10–12]. In typical lab-on-a-chip experiments, a sin-
gle microfluidic chip per extraction and small amounts of 
buffers were used to isolate DNA or RNA in a relatively 
short time (~ 30 min in general) [13–19]. These easy pro-
cesses provided comparable quality of purified nucleic 
acids to those of the conventional protocols in terms of 
polymerase chain reaction (PCR) amplification or gene 
sequencing results [15, 16, 18].
Alternatively, a lab-on-a-chip protocol developed by 
Heller group employed the physical principle of dielec-
trophoresis to isolate cell-free DNA in a ~ 10 min of time 
from blood samples [19–21]. In this physical method, an 
alternative current (AC) electric field was delivered to the 
chip via embedded platinum electrodes, creating local 
electric field divergence [22]. The spatially non-uniform 
electric field and the polarizability differences between 
the biomolecules in blood and the medium generated a 
dielectrophoretic force. Under the AC field with ~ 10  V 
of voltage and kHz-order frequency, the highly charged 
DNA and other less or non-charged particles in blood 
were dielectrophoretically dragged in the opposite direc-
tion to each other [21]. The consequent PCR band inten-
sities of the isolated DNA were at a comparable level to 
those from the conventional columnar kits [22]. In sum-
mary, the lab-on-a-chip methods improved the con-
ventional nucleic acid extraction protocol in terms of 
process simplicity and time, still demonstrating competi-
tive extraction performances. Nevertheless, the meth-
ods still consisted of multiple steps of mainly sequential 
injection of buffers and required heavy apparatus such 
as a liquid injector [15], a centrifuge [14, 18], or a high 
AC field generator [21, 22] for the dielectrophoretic DNA 
separation chip.
In this study, we developed a simpler nucleic acid 
preparation protocol in which direct current (DC) elec-
tric field drew the highly charged DNA or RNA from 
positively charged and weakly or non-charged species in 
biological and clinical samples. Additionally, for separa-
tion, a ~ 100-nm thick fabricated nanoporous membrane 
was inserted to prevent mixing of the sample and col-
lection buffers and to block larger debris in the sample 
from transporting to the collection buffer. By its simple 
electrophoresis principle, this method only required a 
membrane chip, chambers, a pair of electrodes, and a DC 
power supply, where the last can ultimately be replaced 
by batteries used in households to create a compact 
nucleic acid preparation system even suitable for on-site 
operation.
We demonstrated the proof-of-concept experiment of 
the direct electrophoretic nucleic acid preparation and 
that this physical principle and method were compatible 
with popular downstream applications such as PCR [23]. 
After optimizing the experimental parameters including 
operation time and voltage, we performed the nucleic 
acid preparation from the human blood sera. Cell-free 
nucleic acid isolation from blood serum and its analysis 
are a part of liquid biopsy: a new, non-invasive, and cost-
effective cancer prognosis and diagnosis technique in 
which cancer type and stage are identified using tumor-
related genes existing in blood [24–27]. In particular, the 
target nucleic acid in this work was microRNA (miRNA), 
a non-coding gene [28] that regulates the gene expres-
sion [23] and the tumor growth [29, 30], which is rela-
tively complicated to isolate from the blood due to its 
small molecular size [31]. The goal of this work was to 
introduce an easy nucleic acid preparation principle and 
to show that the electrical process worked effectively in 
a challenging application, collecting small miRNA from 
clinical samples. A commercial columnar extraction kit 
was selected as a reference to evaluate the miRNA prepa-
ration performances of the electrical system, where the 
extracted gene levels were compared using quantitative 
reserve transcription PCR (qRT-PCR).
2  Experimental
2.1  Chemicals and reagents
All chemicals and reagents were used as received with-
out further purification. Mature hsa-miR93-5p mimic 
was purchased from Genolution (Seoul, Korea), and tris–
EDTA (TE) buffer (1×, pH 8.0, RNase and DNase free) 
and chloroform were purchased from Sigma Aldrich (St. 
Louis, USA). qRT-PCR was performed using miScript 
II RT Kit, miScript SYBR Green PCR Kit, and miScript 
Primer Assay (hsa-miR93-5p primers) from Qiagen 
(Hilden, Germany). miRNeasy Serum/Plasma Kit from 
Qiagen was used for the chemical extraction of miRNA 
from the sera. Agarose gel, tris acetate-EDTA (TAE) 
buffer, 25/100  bp mixed DNA ladder (all from Bioneer 
Inc., Daejeon, Korea), and gel loading buffer (Bionics, 
Seoul, Korea) were purchased to carry out gel electro-
phoresis. All reagents other than TE and TAE buffer, 
chloroform, agarose gel, gel loading buffer (all at room 
temperature), miRNeasy kit (2–4  °C), and the clinical 
serum samples (−  80  °C) were stored at −  20  °C upon 
receipt. Polydimethysiloxane (PDMS) monomer and cur-
ing agent were purchased from The Dow Chemical Com-
pany (Michigan, USA), and stored at room temperature.
2.2  Nanofilter membrane fabrication
The fabrication procedure started from low-pressure 
chemical vapor deposition (LPCVD) of 500-nm low-
stress silicon nitride  (SiNx) onto a double-side polished 
4-in. silicon (Si) wafer. Nanoimprint resist (poly(urethane 
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acrylate)) was coated on one side of the wafer, where 
the nanopore pattern of 200-nm-large nanopores with 
400-nm center-to-center distances was imprinted using 
pre-made nanoimprint mold [32]. The nanopores were 
pre-defined by partial etch of  SiNx in ~ 100  nm depth 
using inductively coupled plasma (ICP) etcher (Oxford 
Instruments PlasmaPro System100 Cobra), followed by 
the creation of the freestanding membrane according to 
the conventional solid-state nanopore fabrication proto-
col [32]. The imprinted pattern should be etched before 
the membrane fabrication step, and at the same time, the 
 SiNx film should be free of penetrating pores to effec-
tively serve as the Si wet etch mask. As the last step, the 
nanopores were fully perforated by partial dry etch of 
 SiNx from the backside of the predefined area. The mem-
brane thickness was determined by measuring the  SiNx 
thickness of the backside of the supporting chip using 
Nanospec® (Nanometrics Inc.).
2.3  Electrical preparation system setup
Two compartments of custom-made Teflon® flow cells, 
two 1  cm × 1  cm × 2  mm PDMS panels with a 3-mm 
large hole punched at the center, and the nanofilter mem-
brane device were assembled using a pair of screws. To 
construct the PDMS blocks, the elastomer base and the 
curing agent were mixed in a 10:1 weight ratio and the 
mixture was cured at room temperature overnight. The 
volumes of the solutions loaded in the reservoir and the 
collection chambers were 150  µl and 75  µl respectively 
in all nanofilter experiments. Pt electrodes connected 
to a DC power supply (Keithley® 237 instrument) were 
immersed in each chamber. The chambers were reused 
after cleaning with fresh piranha solution for 10 min and 
rinsing with deionized water for 10–15 min. Pt electrodes 
were cleaned after each run with 70% ethanol and deion-
ized water and dried before use.
2.4  miRNA preparation experiments
Before all experiments, clean TE buffer was loaded in 
both chambers and 10 V was applied to either chamber 
to check if the ionic path had been effectively created 
through the nanopores. Then, 150 µl of 100 pg/µl miR93-
5p mimic in TE buffer (reservoir chamber, input) and 
75 µl of bare TE buffer (collection chamber, output) were 
injected to verify the miRNA transport. The applied volt-
age to the collection chamber was 0, 1, 2, 5, and 10 V, and 
each run lasted for 30 min. As above, miRNA was driven 
from the clinical sera of 150 µl volume to 75 µl TE buffer. 
For all serum miRNA collection experiments, 2  V was 
applied for 30 min. The same 150 µl sera were used for 
the chemical extraction using the purchased kit, basically 
following the manufacturer’s protocol except for the last 
elution step: RNase-free water of 75 µl was used instead 
of the suggested volume of 14  µl. All miRNA prepara-
tions were conducted for no less than 3 times for the 
same sample, but the kit extractions from the clinical sera 
were only performed once for each sample due to the 
limited supply of the sera (~ 700 µl for each donor). The 
clinical serum samples used in this work were provided 
by the National Biobank of Korea. The experiments using 
the human blood serum of hepatocellular carcinoma 
patients and healthy individuals were approved by the 
institutional review board of Seoul National University 
(IRB No. E1804/003-004, 2018-04-16).
2.5  qRT‑PCR, gel electrophoresis, and spectrophotometry 
analysis
The reverse transcription (RT) reaction was performed 
no later than a day after the miRNA was collected elec-
trically or chemically. The synthesized complementary 
DNA (cDNA) was stored at − 20 °C before qPCR experi-
ments. RT and qPCR processes all followed the protocol 
provided by the kit manufacturer and were performed 
using Applied Biosystems® 2720 Thermal Cycler (RT) 
and Bio-Rad® CFX384 Touch™ Real-Time PCR Detection 
System (qPCR). RT reaction was completed after two-
step incubations under 37  °C for 60  min and 95  °C for 
5 min. For the cDNA, 45 qPCR cycles (94 °C, 15 s—55 °C, 
30 s—70 °C, 30 s) were performed after the initial activa-
tion step of 95 °C incubation for 15 min. Gel electropho-
resis and imaging were carried out using Mupid® 2-Plus 
electrophoresis system (Advance, Japan) and Gel Doc™ 
XR + system (Bio-rad, USA). The spectrophotometry 
measurements were conducted using Nanodrop® 2000 
from Thermo Fisher Scientific®.
3  Result and discussion
3.1  System setup and fabrication of nanofilter membrane 
device
The schematics and the actual setup of the direct elec-
trophoretic nucleic acid preparation using the nanofilter 
membrane device were displayed in Fig. 1. The principle 
of the electrophoretic preparation was to simply drive the 
negatively charged nucleic acid in the reservoir cham-
ber (sample) to the collection chamber (buffer), where 
the positive voltage was applied via external DC power 
source (Fig.  1a). To construct the electrical preparation 
system, the membrane and the chambers were assembled 
with elastomer gaskets on each side of the chambers to 
prevent leakage of the liquids (Fig.  1b). The sample and 
the collection buffer (1× TE buffer in this work) were 
injected into each chamber, and a pair of electrodes was 
loaded. After setup, the nanopores acted as the separa-
tion layer between the chambers and the only transport 
path for the ions, the fluid, and the biomolecules.
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The nanofilter membrane should prevent the mixing 
of the buffers in the two chambers while facilitating the 
transport of the nucleic acid molecules. In the molecu-
lar transport perspective, conventional molecular filter 
membranes such as track-etched polycarbonate mem-
brane were unfavorable to use in this work because 
their 10 µm-order thicknesses resulted in low molecu-
lar fluxes [33]. In contrast, the membranes of sub-
micron thicknesses were advantageous in promoting 
the molecular transport to the opposite chamber, while 
the thinness may sacrifice the mechanical vulnerability 
of the membranes.
Consequently, to create a thin and robust nanoporous 
membrane, silicon nitride was selected as the membrane 
material and thus semiconductor fabrication technique 
as the device fabrication method. From its excellent 
mechanical robustness and chemical stability,  SiNx thin 
film has been widely used in solid-state nanopore fabrica-
tion [34, 35]. The semiconductor fabrication technology, 
lithography in particular, has a strong advantage in form-
ing a highly aligned structure with designed feature size 
[36, 37]. This allowed the fabrication of a packed, orderly 
network of identical pores.
Figure  2 illustrated the fabrication procedure of the 
nanofilter membrane device with the images of the com-
pleted devices and the porous membrane [32, 34, 35, 
38, 39]. Figure  2a presented the nanofilter membrane 
fabrication sequence, explained in detail in the experi-
mental section. Nanoimprint technique is an efficient 
lithographic method that features a stamping process of a 
reusable polymeric mold onto nanoimprint resist, reduc-
ing time and cost for the fabrication of nanostructures 
[32]. As the result, Fig.  2b, c clearly displayed that the 
nanofilter membrane consisted of well-aligned and uni-
form nanopores of 200-nm diameter was formed at the 
center of a 1 cm × 1 cm chip. The nanopore density cal-
culated from Fig. 2c was 7.22 × 108/cm2.
In determining the dimensions of the pore, the mem-
brane, and the device, the reproducibility in fabrication, 
as well as the separation principle, were considered. 
Since the operation principle was mainly based on the 
electrical charge and the size of the particles, nanopores 
should be small enough to sieve relatively large-sized 
impurities and large enough to allow the flux of small 
particles including nucleic acids [33]. To stably produce 
a well-arranged array of small nanopores of nanom-
eter-level size, 200  nm was selected as the optimum 
pore diameter. Nanoporous membranes with smaller 
pore sizes have been reported in a number of articles 
[40–42]; however, the distinct feature of the nanofilter 
membrane in this work was the ordered network of uni-
form pores spanning in a whole membrane to increase 
the channel area for the biomolecular transport. The 
area (700  μm to 1  mm in width) and the thickness 
(~ 100  nm) of the membrane were determined upon 
its mechanical stability during the electrical prepara-
tion experiments. During the device fabrication, the 
thickness of the membrane was indirectly monitored 
by measuring the  SiNx thickness of the partially etched 
backside of the device using ellipsometry. Finally, the 














Fig. 1 Direct electrophoretic nucleic acid preparation schematics. 
a A model image of the electrophoretic nucleic acid preparation 
system. This image is not in scale. b A photograph of the assembled 
direct preparation cell, with serum and TE buffer inserted in the 
reservoir chamber (left chamber) and the collection chamber (right 
chamber) each
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3.2  Direct and electrophoretic miRNA preparation: 
a proof‑of‑concept
First, to validate that the nucleic acid can electrically trans-
port and be collected across the nanofilter membrane, 
hsa-mir-93-5p (miR93-5p) mimic was electrophoretically 
drawn from the pure miRNA mimic solution with a known 
concentration of 100  pg/µl. In this experiment, 1–10  V 
was applied to the collection chamber for 30 min to drag 
the negatively charged miRNA in the reservoir chamber 
across the membrane. Voltage application time was first 
set as above referring to the previous reports on lab-on-
a-chip nucleic acid extraction protocols [13–18]. Longer 
operation times would allow more miRNA to transport to 
the collection chamber, but the buffers started to dry sig-
nificantly after 30 min, limiting the processing time up to 
half an hour. Closed packaging would enable long-term 
and stable runs, yet still shorter times would be preferable 
in terms of efficiency as long as the collected miRNA is 
analyzable in downstream applications. The input sample 
volume (150 µl in the reservoir chamber) was attributed to 
the commercial columnar-based methods, a reference to 
assess the performance and efficiency of the direct electro-
phoretic preparation system. Following the input volume, 
the output volume was set to 75 μl for stability that the col-
lection buffer stayed intact for 30 min.
The collected miRNA was amplified using qRT-PCR 
to compare the miRNA collection efficiency under each 
applied voltage condition. Threshold cycle  (Ct) val-
ues were obtained in all voltages, indicating that the 
miRNA has transported across the nanofilter mem-
brane under the bias voltage. When the same setup was 
left for 30 min without bias voltage to assess the diffu-
sive contribution to the transport, the miRNA concen-
tration in the collection chamber was less than 5% of 
those collected under the electrically biased conditions. 
This result suggested that the electric field generated by 
the applied voltage was indeed the major driving force 
for the miRNA movement.
To compare the molecular transport by the applied 
voltage and optimize the voltage condition, the col-
lected quantities of miRNA relative to the input were 
calculated from the  Ct values and the buffer volumes. 
Figure 3 presented the transported % of miRNA under 
1, 2, 5, 10 V. Two regions are identifiable in the graph; 
1 V and 2 V with lower percentages but clustered data 
points, and 5 V and 10 V with a couple of points above 
5% but scattered distributions. The data fluctuation at 
5  V and 10  V may be attributed to uneven evapora-
tion and migration of the fluid under these conditions, 
which will be discussed below with graphics. Consid-
ering performance reproducibility, the lower voltages, 
especially 2 V, were the favorable collection voltage in 
this work. Additionally, the molecular stability of the 
collected miRNA was confirmed in gel electrophoresis, 
where the band positions obtained from the collected 
miRNAs corresponded to that from the reference 
miRNA mimic. In conclusion, from the preliminary 
experiments using a known miRNA mimic solution, 
the idea of direct electrophoretic nucleic acid prepara-
tion was practically validated in consecutive qRT-PCR. 
Applying 2 V for 30 min was suitable in terms of quan-














Fig. 2 Nanofilter membrane fabrication. a Fabrication steps of the nanofilter membrane device. The image is not in scale. b A photograph of the 
nanofilter membrane device, the front side (left) and the backside (right). The square membrane is located at the center, having 700 μm width. The 
size of the chips is 1 cm × 1 cm. c A scanning electron microscope (SEM) image of the uniform arrangement of the nanopores in the nanofilter 
membrane. The scale bar indicates 1 μm
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this condition, the average collection rate of miRNA 
from the pure miRNA solution was 12.2 pg/min.
3.3  System stability in the electrophoretic preparation 
setup
As well as the consistency in data, electrical and elec-
trochemical stability of the system during the experi-
ment should be considered for optimizing the collection 
voltage. Ionic current during 30  min and change in the 
chamber and buffer pH after 30-min experiments were 
presented by the applied voltage (Fig.  4). In Fig.  4a, the 
ionic current stayed stable after a capacitive delay at 2 V, 
but the current curve started to decrease after 1200  s 
(5 V) and ~ 200 s (10 V) at the higher voltages.
The reducing ionic current would have resulted 
from the decrease in the collection buffer volumes 
under higher voltages; the buffer partly evaporated and 
migrated to the reservoir chamber. Figure  4b clearly 
showed that the collection buffer was significantly 
depleted after 30-min application of 10  V. Under 5  V, 
though hardly noticeable in the figure, about 20–30% 
of the collection buffer in average moved to the oppo-
site chamber during 30  min while it was steady under 
1–2  V. The direction of the fluid movement was the 
Voltage (V)










1 2 5 10 Ref
Fig. 3 Electrophoretic transport of miRNA across the nanofilter 
membrane. Each diamond point indicates the electrophoretically 
transported quantity of miRNA for 30 min relative to the input in each 
run (n = 7 for each voltage). Inset is a gel image resulting from gel 
electrophoresis of the amplified genes. The numbers labeled in the 
inset indicate the applied voltages in V. The positive control band was 
labeled as ‘Ref’
Fig. 4 Stability during and after the electrophoretic preparation experiments. a Ionic currents during 30 min, b the chambers after 30 min, and c 
pH changes of solutions in the reservoir chamber (Res) and the collection chamber (Col) after 30‑min experiments with the initial buffer pH (TE) 
under 2, 5, 10 V conditions. The measured pH values were labeled on each pH meter paper strip
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same as the electroosmotic flow direction expected 
from the movement of the positive counterion gathered 
near the negatively charged  SiNx surface at pH 8.0 [43]. 
By principle, electroosmotic flow inside the nanopores 
existed also under lower voltages, but the changes in 
the buffer volumes were minimal in these conditions 
presumably due to the lower electric field.
In addition to the change in the collection buffer 
quantity, air bubbles could be found in the chambers at 
5 V and 10 V. As Pt electrodes were used, the evolved 
bubbles would be hydrogen and oxygen generated 
from water electrolysis reaction. The gas evolutions 
were indirectly identifiable through pH alterations of 
the buffers after 30  min (Fig.  4c). The direction of pH 
change corresponded to the water electrolysis reactions 
in a basic solution (pH of TE buffer: 8.0) shown below:
The standard potential (1  M, 25  °C, 1  atm) of this 
reaction is 1.23  V. Under 2  V, although the reaction 
would also have been present, there was a minimal 
effect in disrupting the buffering capability according 
to Fig.  4c. The migration of fluid, the air bubble gen-
erations, and the pH change in solutions after 30-min 
runs were observed in all 5 and 10-V runs. Therefore, 
the electrically induced fluid migration and water elec-
trolysis reaction were active under the high voltages, 
and the instability of the system would have adversely 
affected the reproducibility of the transport yield. To 
summarize, considering the quantitative and qualitative 
discussions above—though miRNA was reported to be 
stable under a wide range of pH [44]—2  V was set as 
(cathode) 4H2O + 4e
− → 2H2 + 4OH
−(pH increase),
(anode) 4OH− → O2 + H2O + 4e
−(pH decrease).
the optimum voltage condition for the electrophoretic 
miRNA collection. Henceforth, all experiments were 
conducted under 2 V for 30 min in the sections below.
3.4  Yield and quality of the electrically collected miRNA
Even though miRNA successfully and stably transported 
across the nanofilter membrane as above, the electri-
cally collected amount of miRNA was as small as a few 
percent of the input quantity (Fig. 3). To analyze the ori-
gin of the migration yield or the electrophoretic driving 
force, the chamber system was constructed as a simple 
circuit model in Fig. 5a. The circuit consisted of a power 
source (V), resistances of the fluidic chambers (Rres, Rcol) 
and the nanopores (Rpore), and the resistive and capaci-
tive components in the electric double layer (EDL) at the 
electrode-solution interface (REDL, CEDL) [45]. Here, the 
capacitance of the silicon chip was neglected from its 
small value (in pF order) [46, 47] and for simplicity. From 
the nonzero saturation current at 2 V in Fig. 4a, the plati-
num electrodes were assumed a realistic electrode, hav-
ing the resistive term REDL [48]. In principle, the electrical 
driving force was proportional to the electric field thus 
the voltage drops in each part of the system: more funda-
mentally, the relative magnitude of each resistance.
To quantitatively identify each component in the cir-
cuit, the ionic current curve was recalled from Fig. 4a. At 
2 V, the time-dependent ionic current can be mathemati-
cally interpreted as in the equation below:
where I(t) is the ionic current at 2 V as a function of time 
t, I(0) is the initial ionic current at t = 0, and I(∞) is the 














































Fig. 5 Working principles of the electrophoretic miRNA preparation method. a A simple circuit model of the electrophoretic system. Each electrical 
component is explained in the text. b Gel image of the miRNA from human blood serum separated using the electrophoretic protocol (E) and the 
commercial kit (K), and the positive control (Ref ). c UV–Vis spectrophotometry result of the electrophoretically collected (upper, red line) and the 
chemically extracted (lower, black line) miRNA. The y‑axis represents the absorbance at 10 mm pathlength
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saturated ionic current [46]. By curve fitting and calcu-
lating the chamber and the nanopore resistance from the 
known dimensions, total EDL resistance was 1.13 × 105 
Ω, Rres + Rcol was 1.23 × 104 Ω, and Rpore was 39.8 Ω.
Calculating from the resistances, nearly 90% of the total 
voltage drop occurred at the electrode-buffer interfaces. 
Pt electrodes were ideal in the electrochemical aspect—
the byproducts of the electrochemical reaction were only 
hydrogen and oxygen—but the electrophoretic driving 
force inside the chambers was substantially reduced by 
the Pt electrode-solution interface. The resistance of the 
parallel-aligned nanopore was minimal in the electri-
cal setup. Nevertheless, due to the ~ 100  nm thickness 
of the membrane, the electric field inside the nanopores 
was as high as 6 × 103 V/m from a simple calculation of 
voltage drop/pore length. This electric field strength was 
higher than that in a typical gel electrophoresis setup 
(~ 100  V/10  cm). Therefore, despite the large parasitic 
resistance at the EDL of the electrode, the electropho-
retic driving force inside the nanopores was effective in 
transporting miRNA across the membrane.
On the other hand, from their millimeter-scale length, 
the electric field inside the chambers was insufficient to 
drive the charged molecules to the high-field nanopore 
region. This was a limitation in the electrical setup in 
this work, where the chamber volume and dimensions 
have been designed with a view to comparison with the 
conventional miRNA extraction methods. Now that the 
electrophoretic preparation strategy was proven valid in 
this work, a microfluidic structure would be an efficient 
improvement of the fluidic chambers to exert adequate 
electric field throughout the whole system and increase 
the migration efficiency.
To confirm the feasibility of the direct electrophoretic 
preparation from clinical samples, miRNA was collected 
from human blood serum using the electrophoretic 
nanofilter system and the conventional columnar method 
as a reference. As previously mentioned, the input sample 
and the output buffer volumes were fixed to 150 µl and 
75  µl respectively in all experiments. In the electropho-
retic trials, 2-V, 30-min condition was employed and TE 
buffer was used as the collection buffer.
From the sequential gel electrophoresis result in 
Fig.  5b, the preparations of miRNA from a clinical 
sample were successful in both protocols. Therefore, 
the electrophoretic preparation system was also capa-
ble of collecting miRNA from the serum and compat-
ible with qRT-PCR. Further, to identify the chemical 
components in the collection buffer after the experi-
ment, spectrophotometry analysis was performed for 
both samples (Fig. 5c). The absorbance spectrum of the 
directly collected miRNA exhibited a peak at 280  nm 
wavelength, representing the presence of proteins in 
the solution (Fig. 5c, upper panel). A260/280 purity of 
the electrophoretically prepared solution was 0.594, 
also corresponding to the value of protein [49]. In 
contrast, the absorbance spectrum of the chemically 
extracted miRNA solution showed no sign of protein as 
they were excluded and washed out during the extrac-
tion process. A260/280 purity of the conventionally 
extracted solution was 1.72. Instead, a peak at 270 nm 
was observed in the spectrum (Fig.  5c, lower panel), 
representing phenol residue from the lysis reagent used 
in the extraction protocol. Phenol is a PCR inhibitor 
known to degrade the DNA polymerase [50]. A 260-
nm peak, indicating the presence of nucleic acids, was 
absent in both spectra. This observation was reasonable 
though, from that the typical miRNA concentration in 
blood serum was lower than the detection limit of the 
spectrometer used in this study [26, 51].
Hence, protein co-migration along with miRNA appar-
ently existed in the electrical setup, where the nanofilter 
membrane was incapable of completely blocking the neg-
atively charged proteins in the blood sera moving in the 
same direction as miRNA. By principle, the electropho-
retic transport mechanism applied to all charged particles 
in the chambers, including nucleic acids, albumins, and 
globulins, where the last two are negatively charged pro-
teins abundantly existing in blood serum [52]. Therefore, 
a fundamental solution to eliminate the proteins from 
transporting with nucleic acids would be separation by 
size. However, the differences in the diameters of nucleic 
acid strands (single-strand: ~ 1 nm, double-strand: ~ 2 nm) 
and the proteins (albumins and globulins in blood serum: 
4–5 nm to < 10 nm) are only a few nanometers [53], thus 
the window for the separation is limited. Another limita-
tion to the separation by size is difficulties in fabrication of 
nanoporous structure with uniform few-nm sized nanop-
ores. Nevertheless, despite the imperfect separation, from 
Fig.  5b and the results in the section below, the electro-
phoretically collected miRNA was still able to be analyzed 
by the consecutive qPCR.
In summary, the electrophoretic miRNA collection 
protocol showed limitations of low miRNA transport 
yields and imperfect separation of the nucleic acids 
from proteins in clinical samples. The low yield and 
specificity in the electrophoretic transport were native 
issues in the system, where the electrochemically 
favorable Pt electrodes acted as a large parasitic resist-
ance and the electrophoretic migration heavily relied 
on the electrical nature of the biomolecules. Neverthe-
less, the validity of the direct electrophoretic miRNA 
preparation method was still proven from the gel image 
of the collected miRNA from clinical serum samples.
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3.5  Direct electrophoretic miRNA preparation from human 
blood sera
As the final demonstration of the direct miRNA prepa-
ration from clinical samples, the same procedure was 
conducted with the serum donated by hepatocellular 
carcinoma (HCC) patients and healthy individuals. In 
liquid biopsy studies, miR93-5p concentrations in the 
tissue and the blood were reported to be upregulated in 
diverse cancer patients including HCC compared to the 
control healthy group [30, 54–57]. Similar to the previous 
section, miRNA was prepared from each serum of 150 µl 
chemically (using the column-based kit) and physically 
(using the electrophoretic preparation system and nano-
filter membrane) to 75 µl of the clean solution to proceed 
to qRT-PCR. The amplification results were presented 
in Fig.  6. As previously mentioned, the conventional 
method could only be performed once due to the limited 
amount of the sample provided, while the electrophoretic 
experiments were repeated 3 times. Interestingly, the  Ct 
value from the electrophoretic preparation was compara-
ble to those obtained from the conventional extractions 
of the same sample. The average  Ct values from the HCC 
patients were 32.38 (kit extraction) and 32.69 (electro-
phoretic preparation) when the values from the healthy 
controls were 33.83 (kit) and 34.06 (electrical). There-
fore, the degradation of the qPCR efficiency was small on 
average, or it was rather insignificant considering that the 
physical protocol also allowed some protein molecules to 
move along with miRNA. The average miR93-5p levels in 
the two groups were close to each other, which was an 
unexpected trend. One recognizable reason would be the 
small sample size (n = 5 for each group). In conclusion, 
the direct electrophoretic system was capable of collect-
ing miRNA from human blood sera in both experiments, 
and the collected gene was identifiable and analyzable 
using qRT-PCR.
To summarize, the simple electrical method was suc-
cessful in collecting miRNA from the clinical serum 
samples and was compatible with the conventional 
downstream application of genetic analysis, despite the 
impurities transported with miRNA that may have nega-
tively affected PCR amplification.
4  Conclusion
The nucleic acid preparation system based on the elec-
trophoretic transport of the negatively charged DNA and 
RNA was introduced, and its performance was examined 
targeting the small miRNA. The new electrophoretic sys-
tem was set up by a simple assembly of the components 
including the nanofilter membrane device with a 100-nm 
thickness, fabricated using top-down technique includ-
ing nanoimprint. After verification of the electrophoretic 
transport of miR93-5p and optimization of the voltage, 
the system was applied in miRNA collection from human 
blood serum. The electrophoretic miRNA preparation 
from the clinical serum samples was successful in that 
the miRNA levels in the sera were detectable and analyz-
able using the new system.
Given that the operation was simple, handy, and 
portable, the electrophoretic strategy demonstrated its 
effectivity and significance as a new means of nucleic 
acid preparation. As discussed in the introduction, 
Sample ID










Fig. 6 miRNA preparation from clinical human serum samples. miR93‑5p was amplified from the miRNA solution collected from the sera of HCC 
patients (labeled as ‘P’) and the control group (labeled as ‘C’), which were prepared using the commercial Qiagen® kit (black bars) and the direct 
electrophoretic system (red bars). The red error bars were calculated from 3 individual electrophoretic collections
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the conventional extraction method has clear limita-
tions of complexity in operation, though the protocol 
is well-established in laboratories and the market. On 
the other hand, the electrophoretic protocol introduced 
in this work could be completed only in 30 min, when 
the columnar method required 1–1.5  h to obtain the 
eluted miRNA. In addition, the new method has several 
practical advantages over the conventional counterpart: 
centrifuge-free, portable using small batteries as the DC 
power source, and less relying on the skills of opera-
tors. The time-efficient and simple process showed 
comparable performances to those of the columnar 
kit. Therefore, the new electrophoretic protocol has 
potential as an easy-access on-site nucleic acid prepara-
tion tool. Even though the electrical system possessed 
inherent limitations such as insufficient sieving of pro-
teins, the simple and physical protocol to collect DNA 
and RNA clearly worked, and even challenging tasks 
such as miRNA liquid biopsy from clinical blood serum 
could be performed using the electrophoretic isolation 
system.
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